Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 Dehydroxybaccatine VI. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of C-13 and C-14 modified taxane derivatives via patent CN107188895B. Offers improved anticancer activity and reduced toxicity for reliable pharmaceutical intermediate supply.